Alejandro José Quiroz Alfaro MD , Noah E. Russell DO , Ruhul Munshi MD , Waleed Hassan MD , James E. Stone MD , Elsheikh M. Abdelrahim MD , Karl J. Crossen MD , Karthik Venkatesh Prasad MD
{"title":"Percutaneous left atrial appendage closure using a modified single-operator-technician approach under deep sedation: A single-center experience","authors":"Alejandro José Quiroz Alfaro MD , Noah E. Russell DO , Ruhul Munshi MD , Waleed Hassan MD , James E. Stone MD , Elsheikh M. Abdelrahim MD , Karl J. Crossen MD , Karthik Venkatesh Prasad MD","doi":"10.1016/j.hroo.2024.10.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Historically, percutaneous transcatheter left atrial appendage closure (LAAC) has been performed under general anesthesia (GA) with transesophageal echocardiographic images obtained by a noninvasive cardiologist and usually requires an overnight hospital stay. Alternatively, we present our single-center experience performing LAACs under deep sedation (DS), employing an echocardiographic technician instead of a noninvasive cardiologist, and expediting same-day discharge. Mid- to long-term outcomes were also evaluated with follow-up imaging at a 45-day visit.</div></div><div><h3>Objective</h3><div>The purpose of this study was to demonstrate the safety, feasibility, and outcomes of our single-operator-technician LAAC approach.</div></div><div><h3>Methods</h3><div>A total of 150 patients, with elevated CHA<sub>2</sub>DS<sub>2</sub>-VASc scores (a mean of 4 points), underwent transesophageal echocardiography–guided LAAC using the WATCHMAN FLX (Boston Scientific, Marlborough, MA) device under DS.</div></div><div><h3>Results</h3><div>The mean age of patients was 78 years. Seventy-six (51%) were men. One hundred forty-seven patients (98%) had the LAAC device successfully implanted, and 145 (97%) were discharged on the same day. Nine patients (6%) required conversion from DS to GA. Only 5 patients (4%) had complications during the procedure. None of the patients died or had complications from DS. During the 45-day follow-up visit, one patient had a significant peridevice leak (maximum diameter ≥ 5 mm) and another patient had device-related thrombosis.</div></div><div><h3>Conclusion</h3><div>Our novel single-operator-technician approach under DS is safe and feasible. Implementing protocols to simplify the traditional 2-operator approach under GA by using DS and an echocardiography technician as well as incorporating same-day discharge could make LAACs more widely available and potentially reduce procedural costs.</div></div>","PeriodicalId":29772,"journal":{"name":"Heart Rhythm O2","volume":"5 12","pages":"Pages 936-941"},"PeriodicalIF":2.5000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11721720/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart Rhythm O2","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666501824003295","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Historically, percutaneous transcatheter left atrial appendage closure (LAAC) has been performed under general anesthesia (GA) with transesophageal echocardiographic images obtained by a noninvasive cardiologist and usually requires an overnight hospital stay. Alternatively, we present our single-center experience performing LAACs under deep sedation (DS), employing an echocardiographic technician instead of a noninvasive cardiologist, and expediting same-day discharge. Mid- to long-term outcomes were also evaluated with follow-up imaging at a 45-day visit.
Objective
The purpose of this study was to demonstrate the safety, feasibility, and outcomes of our single-operator-technician LAAC approach.
Methods
A total of 150 patients, with elevated CHA2DS2-VASc scores (a mean of 4 points), underwent transesophageal echocardiography–guided LAAC using the WATCHMAN FLX (Boston Scientific, Marlborough, MA) device under DS.
Results
The mean age of patients was 78 years. Seventy-six (51%) were men. One hundred forty-seven patients (98%) had the LAAC device successfully implanted, and 145 (97%) were discharged on the same day. Nine patients (6%) required conversion from DS to GA. Only 5 patients (4%) had complications during the procedure. None of the patients died or had complications from DS. During the 45-day follow-up visit, one patient had a significant peridevice leak (maximum diameter ≥ 5 mm) and another patient had device-related thrombosis.
Conclusion
Our novel single-operator-technician approach under DS is safe and feasible. Implementing protocols to simplify the traditional 2-operator approach under GA by using DS and an echocardiography technician as well as incorporating same-day discharge could make LAACs more widely available and potentially reduce procedural costs.